Perrigo | PRGO - Operating Expenses


Perrigo reported $290.5M in Operating Expenses for its fiscal quarter ending in June of 2026.





Operating Expenses Change Date
AbbVie USD 10.27B 1000K Jun/2026
Abbott USD 11.66B 1.2B Sep/2026
Bayer EUR 10.04B 168M Jun/2026
Bristol-Myers Squibb USD 22.32B 2.25B Jun/2026
Coherus Biosciences USD 51.83M 2.48M Dec/2025
Corcept Therapeutics USD 214.85M 343K Jun/2026
Dr.Reddys Laboratories INR 74.82B 2.93B Sep/2026
Eli Lilly USD 10.52B 496M Jun/2026
J&J USD 18.93B 1.09B Sep/2026
Merck USD 15.77B 2.4B Jun/2026
Nestle CHF 36.13B 2.29B Jun/2026
Pacira USD 180.54M 7.79M Jun/2026
Perrigo USD 290.5M 645.1M Jun/2026
Pfizer USD 85.19B 4.91B Jun/2026
Phibro Animal Health USD 361.83M 29.47M Mar/2026
Prestige Brands USD 213.19M 7.06M Jun/2026
Reckitt Benckiser GBP 6.26B 3.51B Dec/2024
Sanofi EUR 9.92B 607M Jun/2026
Supernus Pharmaceuticals USD 1.03B 45.58M Jun/2026
Teva Pharmaceutical Industries USD 3.92B 691M Jun/2026
Xeris Pharmaceuticals USD 75.21M 6.18M Mar/2026
Zoetis USD 3.15B 85M Jun/2026